Leo withdraws plans to launch OTC version of Dovonex

Leo withdraws plans to launch OTC version of Dovonex

September 20 2017 Leo Pharma has announced it will not now launch an over-the-counter version of...

Boots introduces generic levonorgestrel for EHC service

Boots introduces generic levonorgestrel for EHC service

September 4 2017 Boots has announced it is starting to make available a cheaper generic...

Which? challenges effectiveness, variety and cost of branded OTC medicines

Which? challenges effectiveness, variety and cost of branded OTC medicines

August 29 2017 Which? has published an article questioning the effectiveness of some over the...

Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

August 25 2017 Using dietary supplements containing anti-oxidants, zinc and copper can help delay...

Case report concludes zinc in denture fixative caused numbness and muscle weakness

Case report concludes zinc in denture fixative caused numbness and muscle weakness

August 11 2017 Excessive use of a dental fixative containing zinc has been deemed the likely...

  • Leo withdraws plans to launch OTC version of Dovonex

    Leo withdraws plans to launch OTC version of Dovonex

    Wednesday, 20 September 2017 14:11
  • Boots introduces generic levonorgestrel for EHC service

    Boots introduces generic levonorgestrel for EHC service

    Monday, 04 September 2017 15:09
  • Which? challenges effectiveness, variety and cost of branded OTC medicines

    Which? challenges effectiveness, variety and cost of branded OTC medicines

    Tuesday, 29 August 2017 15:16
  • Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

    Combination anti-oxidant, zinc and copper supplements protect against degenerative eye disorders

    Friday, 25 August 2017 13:36
  • Case report concludes zinc in denture fixative caused numbness and muscle weakness

    Case report concludes zinc in denture fixative caused numbness and muscle weakness

    Monday, 14 August 2017 09:03

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Pharmacy Image cbAugust 29 2017

Which? has published an article questioning the effectiveness of some over the counter medicines, and advising its readers to consider cheaper alternatives to branded items.

Appearing in the September issue, the article “names the widely available medicines and supplements that aren’t all they’re cracked up to be.” It covers 10 brands including cold and flu remedies, analgesics, oral care, ear drops and vitamin and mineral supplements.

It argues that it is not always possible to decide whether OTC products are worth the money, and that there are often “far cheaper alternatives that work just as well.” It also calls on manufacturers to be more open in publishing efficacy evidence. “In the meantime, be sure to ask the pharmacist any questions about the products, and check the key active ingredients to see if you can find a cheaper alternative,” it tells its readers.

Responding to the article, the branded OTC manufacturers’s trade body, the Proprietary Association of Great Britain, said the wide range of branded and generic OTC medicines, ensures people have a choice to suits their needs and their budget.

John Smith, PAGB Chief Executive, commented: “Branded OTC medicines enjoy a long-standing heritage of trust and manufacturers invest heavily in research and product development. In order for a medicine to be granted a licence, manufacturers must provide robust evidence to show it is effective before it can be sold in pharmacies and other retail stores.

“The manufacturers behind the well-known brands are often first to bring medicines to market with benefits such as a faster onset of action, prolonged duration or products that were previously only available on prescription. As Which? points out, some OTC products are marketed to target specific symptoms, this is because having these displayed on the front of the pack helps people choose a suitable product more easily, particularly in a shop where there isn’t a pharmacist to ask.

“Unlike new prescription drugs, which enjoy lengthy patent protection, it is exceedingly rare for new OTC medicines to have any form of protection once launched. Other companies are then free to produce and sell copies or generics at a lower price, because they don’t have to carry out the research and development. It is for these reasons of commercial confidentiality that detailed data on product efficacy is only shared with regulators.

“We support the Which? recommendation to always read the label and if people are still unsure, they should consult a pharmacist. Pharmacists are expert healthcare professionals who can provide information and support to help you to self care.”

Links:
Which?                                 
PAGB comment                  

 

OTC News

September 21 2017 Pharmacy IT systems supplier Cegedim has announced it has commenced beta testing of Pharmacy Manager version 10.3. The new version has specific functionalities for England and...
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...